Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


ADC Therapeutics Announces First Patient Dosed With Camidanlumab Tesirine With Pembrolizumab In Phase 1b Trial


RTTNews | Nov 3, 2020 07:20AM EST

07:19 Tuesday, November 3, 2020 (RTTNews) - ADC Therapeutics Announces First Patient Dosed With Camidanlumab Tesirine With Pembrolizumab In Phase 1b Trial

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2020 RTTNews.com. All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC